United States Oligonucleotide Synthesis Market Report 2017

August 2017 | 106 pages | ID: UC979263141EN
QYResearch

Abstracts

In this report, the United States Oligonucleotide Synthesis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Oligonucleotide Synthesis in these regions, from 2012 to 2022 (forecast).

United States Oligonucleotide Synthesis market competition by top manufacturers/players, with Oligonucleotide Synthesis sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Genescript
• GeneArt (Thermofischer)
• IDT
• DNA 2.0 (ATUM)
• OriGene
• BBI
• Genewiz
• Eurofins Genomics
• Gene Oracle
• SBS Genetech
• Bio Basic

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Primers
• Probes
• Intermediate-scale Synthesis Oligos
• Large-scale Synthesis Oligos
• Linkers and Adaptors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oligonucleotide Synthesis for each application, including

• Commercial
• Academic Research

Contents

United States Oligonucleotide Synthesis Market Report 2017

1 OLIGONUCLEOTIDE SYNTHESIS OVERVIEW

1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Classification of Oligonucleotide Synthesis by Product Category
  1.2.1 United States Oligonucleotide Synthesis Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Oligonucleotide Synthesis Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Primers
  1.2.4 Probes
  1.2.5 Intermediate-scale Synthesis Oligos
  1.2.6 Large-scale Synthesis Oligos
  1.2.7 Linkers and Adaptors
1.3 United States Oligonucleotide Synthesis Market by Application/End Users
  1.3.1 United States Oligonucleotide Synthesis Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Commercial
  1.3.3 Academic Research
1.4 United States Oligonucleotide Synthesis Market by Region
  1.4.1 United States Oligonucleotide Synthesis Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Oligonucleotide Synthesis Status and Prospect (2012-2022)
  1.4.3 Southwest Oligonucleotide Synthesis Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Oligonucleotide Synthesis Status and Prospect (2012-2022)
  1.4.5 New England Oligonucleotide Synthesis Status and Prospect (2012-2022)
  1.4.6 The South Oligonucleotide Synthesis Status and Prospect (2012-2022)
  1.4.7 The Midwest Oligonucleotide Synthesis Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oligonucleotide Synthesis (2012-2022)
  1.5.1 United States Oligonucleotide Synthesis Sales and Growth Rate (2012-2022)
  1.5.2 United States Oligonucleotide Synthesis Revenue and Growth Rate (2012-2022)

2 UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oligonucleotide Synthesis Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oligonucleotide Synthesis Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oligonucleotide Synthesis Average Price by Players/Suppliers (2012-2017)
2.4 United States Oligonucleotide Synthesis Market Competitive Situation and Trends
  2.4.1 United States Oligonucleotide Synthesis Market Concentration Rate
  2.4.2 United States Oligonucleotide Synthesis Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oligonucleotide Synthesis Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OLIGONUCLEOTIDE SYNTHESIS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Oligonucleotide Synthesis Sales and Market Share by Region (2012-2017)
3.2 United States Oligonucleotide Synthesis Revenue and Market Share by Region (2012-2017)
3.3 United States Oligonucleotide Synthesis Price by Region (2012-2017)

4 UNITED STATES OLIGONUCLEOTIDE SYNTHESIS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Oligonucleotide Synthesis Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oligonucleotide Synthesis Revenue and Market Share by Type (2012-2017)
4.3 United States Oligonucleotide Synthesis Price by Type (2012-2017)
4.4 United States Oligonucleotide Synthesis Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OLIGONUCLEOTIDE SYNTHESIS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oligonucleotide Synthesis Sales and Market Share by Application (2012-2017)
5.2 United States Oligonucleotide Synthesis Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OLIGONUCLEOTIDE SYNTHESIS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Genescript
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genescript Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GeneArt (Thermofischer)
  6.2.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GeneArt (Thermofischer) Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 IDT
  6.3.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IDT Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 DNA 2.0 (ATUM)
  6.4.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 OriGene
  6.5.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 OriGene Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BBI
  6.6.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BBI Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Genewiz
  6.7.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Genewiz Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eurofins Genomics
  6.8.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eurofins Genomics Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gene Oracle
  6.9.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gene Oracle Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 SBS Genetech
  6.10.2 Oligonucleotide Synthesis Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 SBS Genetech Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Bio Basic

7 OLIGONUCLEOTIDE SYNTHESIS MANUFACTURING COST ANALYSIS

7.1 Oligonucleotide Synthesis Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oligonucleotide Synthesis

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oligonucleotide Synthesis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Oligonucleotide Synthesis Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oligonucleotide Synthesis Sales Volume Forecast by Type (2017-2022)
11.3 United States Oligonucleotide Synthesis Sales Volume Forecast by Application (2017-2022)
11.4 United States Oligonucleotide Synthesis Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oligonucleotide Synthesis
Figure United States Oligonucleotide Synthesis Market Size (K Units) by Type (2012-2022)
Figure United States Oligonucleotide Synthesis Sales Volume Market Share by Type (Product Category) in 2016
Figure Primers Product Picture
Figure Probes Product Picture
Figure Intermediate-scale Synthesis Oligos Product Picture
Figure Large-scale Synthesis Oligos Product Picture
Figure Linkers and Adaptors Product Picture
Figure United States Oligonucleotide Synthesis Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Oligonucleotide Synthesis by Application in 2016
Figure Commercial Examples
Figure Academic Research Examples
Figure United States Oligonucleotide Synthesis Market Size (Million USD) by Region (2012-2022)
Figure The West Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2022)
Figure United States Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oligonucleotide Synthesis Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Oligonucleotide Synthesis Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Oligonucleotide Synthesis Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oligonucleotide Synthesis Sales Share by Players/Suppliers
Figure 2017 United States Oligonucleotide Synthesis Sales Share by Players/Suppliers
Figure United States Oligonucleotide Synthesis Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oligonucleotide Synthesis Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oligonucleotide Synthesis Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oligonucleotide Synthesis Revenue Share by Players/Suppliers
Figure 2017 United States Oligonucleotide Synthesis Revenue Share by Players/Suppliers
Table United States Market Oligonucleotide Synthesis Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Oligonucleotide Synthesis Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Oligonucleotide Synthesis Market Share of Top 3 Players/Suppliers
Figure United States Oligonucleotide Synthesis Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oligonucleotide Synthesis Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oligonucleotide Synthesis Product Category
Table United States Oligonucleotide Synthesis Sales (K Units) by Region (2012-2017)
Table United States Oligonucleotide Synthesis Sales Share by Region (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Share by Region (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Market Share by Region in 2016
Table United States Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oligonucleotide Synthesis Revenue Share by Region (2012-2017)
Figure United States Oligonucleotide Synthesis Revenue Market Share by Region (2012-2017)
Figure United States Oligonucleotide Synthesis Revenue Market Share by Region in 2016
Table United States Oligonucleotide Synthesis Price (USD/Unit) by Region (2012-2017)
Table United States Oligonucleotide Synthesis Sales (K Units) by Type (2012-2017)
Table United States Oligonucleotide Synthesis Sales Share by Type (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Share by Type (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Market Share by Type in 2016
Table United States Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oligonucleotide Synthesis Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oligonucleotide Synthesis by Type (2012-2017)
Figure Revenue Market Share of Oligonucleotide Synthesis by Type in 2016
Table United States Oligonucleotide Synthesis Price (USD/Unit) by Types (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Growth Rate by Type (2012-2017)
Table United States Oligonucleotide Synthesis Sales (K Units) by Application (2012-2017)
Table United States Oligonucleotide Synthesis Sales Market Share by Application (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Market Share by Application (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Market Share by Application in 2016
Table United States Oligonucleotide Synthesis Sales Growth Rate by Application (2012-2017)
Figure United States Oligonucleotide Synthesis Sales Growth Rate by Application (2012-2017)
Table Genescript Basic Information List
Table Genescript Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genescript Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure Genescript Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure Genescript Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table GeneArt (Thermofischer) Basic Information List
Table GeneArt (Thermofischer) Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GeneArt (Thermofischer) Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure GeneArt (Thermofischer) Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure GeneArt (Thermofischer) Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table IDT Basic Information List
Table IDT Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IDT Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure IDT Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure IDT Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table DNA 2.0 (ATUM) Basic Information List
Table DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure DNA 2.0 (ATUM) Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table OriGene Basic Information List
Table OriGene Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OriGene Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure OriGene Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure OriGene Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table BBI Basic Information List
Table BBI Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BBI Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure BBI Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure BBI Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table Genewiz Basic Information List
Table Genewiz Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genewiz Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure Genewiz Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure Genewiz Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table Eurofins Genomics Basic Information List
Table Eurofins Genomics Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eurofins Genomics Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure Eurofins Genomics Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure Eurofins Genomics Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table Gene Oracle Basic Information List
Table Gene Oracle Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gene Oracle Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure Gene Oracle Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure Gene Oracle Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table SBS Genetech Basic Information List
Table SBS Genetech Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SBS Genetech Oligonucleotide Synthesis Sales Growth Rate (2012-2017)
Figure SBS Genetech Oligonucleotide Synthesis Sales Market Share in United States (2012-2017)
Figure SBS Genetech Oligonucleotide Synthesis Revenue Market Share in United States (2012-2017)
Table Bio Basic Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oligonucleotide Synthesis
Figure Manufacturing Process Analysis of Oligonucleotide Synthesis
Figure Oligonucleotide Synthesis Industrial Chain Analysis
Table Raw Materials Sources of Oligonucleotide Synthesis Major Players/Suppliers in 2016
Table Major Buyers of Oligonucleotide Synthesis
Table Distributors/Traders List
Figure United States Oligonucleotide Synthesis Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oligonucleotide Synthesis Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Type in 2022
Table United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Application in 2022
Table United States Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Oligonucleotide Synthesis Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oligonucleotide Synthesis Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oligonucleotide Synthesis Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources